Company info

Company Profile

Enveric Biosciences (NASDAQ: ENVB) is a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders. Enveric iS committed to developing novel treatments to transform the lives of patients living with mental illness. We are pursuing new pathways and targeting impaired neural circuitry with the goal of improving brain health. Our mission is to pioneer new and innovative solutions with the potential to have profound effects on patients and their families, and to deliver life-changing medicines for diseases affecting the brain. Enveric is headquartered in Naples, FL with offices in Cambridge, MA and Calgary, AB Canada.

Explore Leadership Team

IR Contacts

Investor Relations

Tiberend Strategic Advisors

Daniel Kontoh-Boateng
(862) 213-1398

Jonathan Nugent
(205) 566-3026


Tiberend Strategic Advisors

Casey McDonald
(646) 577-8520

Dave Schemelia
(609) 468-9325

Friedman LLP
100 Eagle Rock Avenue, Suite 200
East Hanover, NJ 07936
(973) 929-3500

Transfer Agent
American Stock Transfer and Trust Co.
(800) 937-5449

U.S. Legal Council
Haynes and Boone, LLP
30 Rockefeller Plaza, 26th Floor
New York, NY 10112
(212) 659-7300

Frequently Asked Questions

What is Enveric Biosciences?
What year was Enveric Biosciences founded?
Where is Enveric Biosciences incorporated?